(1) Schedin-Weiss S, Inoue M, Hromadkova L, et al. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Alzheimer's research & therapy (2017) 9: 1-19.
(2) Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. New England Journal of Medicine (2016) 375: 2519-2529.
(3) Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. New England Journal of Medicine (1997) 336: 912-918.
(4) Harris RE. Ibuprofen in the prevention and therapy of cancer. Ibuprofen: Discovery, Development and Therapeutics (2015) 518-546.
(5) Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 76: 863-869.
(6) Woodling NS, Colas D, Wang Q, et al. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice. Brain (2016)139: 2063-2081.
(7) Angadi SS, Karn A. Ibuprofen induced Stevens-Johnson syndrome-toxic epidermal necrolysis in Nepal. Asia Pacific Allergy (2016) 6: 70-73.
(8) Ding T, Yang M, Zhang J, et al. Toxicity, degradation and metabolic fate of ibuprofen on freshwater diatom Navicula sp. Journal of hazardous materials (2017) 330: 127-134.
(9) Weiser T, Richter E, Hegewisch A, Muse DD, Lange R. Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction. European journal of pain (London, England) (2018) 22: 28-38.
(10) Rainsford K. Ibuprofen in Prevention of Neurodegenerative Diseases. Ibuprofen: Discovery, Development and Therapeutics, chapter 14, (2015) 547-570.
(11) Choi SH, Aid S, Caracciolo L, et al. Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease. Journal of neurochemistry 2013; 124: 59-68.
(12) Azodi MZ, Rezaei-Tavirani M, Rostami-Nejad M, Rezaei-Tavirani M. Comparative Bioinformatics Characteristic of Bladder Cancer Stage 2 from Stage 4 Expression Profile: A Network-Based Study. Galen Medical Journal (2018)7:1-8.
(13) Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic acids research (2012) 41: 991-995.
(14) Mahboubi M, Rezaei Tavirani M, Mansouri V, Ahmadi NA, Hamdieh M, Rezaei Tavirani M. Protein-Protein Interaction Analysis of Common Top Genes in Obsessive-Compulsive disorder (OCD) and Schizophrenia: Towards New Drug Approach. Iranian Journal of Pharmaceutical Research (2018)
(15) Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research (2003) 13: 2498-2504.
(16) Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic acids research (2016) 937.
(17) Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics (2007) 24: 282-284.
(18) Bindea G, Galon J, Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics (2013) 29: 661-663.
(19) Swomley AM, Förster S, Keeney JT, et al. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease (2014) 1842: 1248-1257.
(20) Taylor G, Carter G, Crow T, et al. Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Experimental and molecular pathology (1986) 44: 111-116.
(21) Calon F, Birdi S, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias. Journal of Neuropathology & Experimental Neurology (2002) 61: 186-196.
(22) Anderson AJ, Cummings BJ, Cotman CW. Increased immunoreactivity for Jun-and Fos-related proteins in Alzheimer's disease: association with pathology. Experimental neurology (1994) 125: 286-295.